How do you manage a patient with decreased but residual PET activity following concurrent chemoRT and PCI for limited stage SCLC?

Would you repeat PET or is it adequate to change to CT surveillance? Although surveillance PET/CT is not recommended by NCCN guidelines, these are often ordered as follow up scans by other providers.

Answer from: Medical Oncologist at Academic Institution

I agree with @Andrew T. Turrisi. There are too many false positive PET scans in the mediastinum. There is no effective second line therapy. Only under the rarest of situations would we consider biopsy to prove this is persistent SCLC and consider surgical resection. The best advice I could give woul...

Comments

Radiation Oncologist at Caribbean Radiation Oncology Center
Agree with that FDG PET CT are expensive and post ...

Answer from: Radiation Oncologist at Community Practice

I think I was the last to know that PET was OK in initial staging, and I will be the last to think PET is worth the price in re-stage. Until we find curative salvage for SCLC, early detection of recurrence or residual is not worth the price. And applying a “treat oligometastasis” argumen...

Please select the option that best describes you:

How do you manage a patient with decreased but residual PET activity following concurrent chemoRT and PCI for limited stage SCLC?

Related Questions